The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016. But Mylan became the first of a group of potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback